Drug development for neurodegenerative diseases : role of PET : Potential of PET in drug discovery and developmentRINNE, J. O.Annals of medicine (Helsinki). 1999, Vol 31, Num 6, pp 444-449, issn 0785-3890Article

Muscarinic and dopaminergic receptors in the aging human brainRINNE, J. O.Brain research. 1987, Vol 404, Num 1-2, pp 162-168, issn 0006-8993Article

Nigral degeneration in Parkinson's disease in relation to clinical featuresRINNE, J. O.Acta neurologica Scandinavica. Supplementum. 1991, Vol 84, Num 136, pp 87-90, issn 0065-1427Article

Age-dependent decline in human brain dopamine D₁ and D₂ receptorsRINNE, J. O; LÖNNBERG, P; MARJAMÄKI, P et al.Brain research. 1990, Vol 508, Num 2, pp 349-352, issn 0006-8993Article

Treatment of early Parkinson's disease with controlled-release levodopa preparationsRINNE, U. K; RINNE, J. O.Neurology. 1990, Vol 39, Num 11, pp 78-81, issn 0028-3878, 4 p., SUPLT2Conference Paper

Human brain methionine- and leucine-enkephalins and their receptors during ageingRINNE, J. O; LÖNNBERG, P; MARJAMÄKI, P et al.Brain research. 1993, Vol 624, Num 1-2, pp 131-136, issn 0006-8993Article

Nigral degeneration in Parkinson's diseaseRINNE, J. O.Movement disorders. 1993, Vol 8, pp S31-S35, issn 0885-3185, SUP1Conference Paper

Picture naming deficits in vascular dementia and Alzheimer's diseaseLAINE, M; VUORINEN, E; RINNE, J. O et al.Journal of clinical and experimental neuropsychology. 1997, Vol 19, Num 1, pp 126-140, issn 0168-8634Article

Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's diseaseRINNE, J. O; PALJÄRVI, L; RINNE, U. K et al.Journal of the neurological sciences. 1987, Vol 79, Num 1-2, pp 67-76, issn 0022-510XArticle

Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageingKEMPPAINEN, N; MARJAMÄKI, P; RÖYTTÄ, M et al.Journal of neural transmission. 2001, Vol 108, Num 7, pp 827-836, issn 0300-9564Article

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's diseaseRINNE, J. O; MYLLYKYLA, T; LONNBERG, P et al.Brain research. 1991, Vol 547, Num 1, pp 167-170, issn 0006-8993, 4 p.Article

Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's diseaseRINNE, J. O; LONNBERG, P; MARJAMAKI, P et al.Brain research. 1989, Vol 483, Num 2, pp 402-406, issn 0006-8993Article

Pet shows that striatal dopamine D1 and D2 receptors are differentially affected in ADKEMPPAINEN, N; RUOTTINEN, H; NAGREN, K et al.Neurology. 2000, Vol 55, Num 2, pp 205-209, issn 0028-3878Article

Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathologyMATTILA, P. M; RINNE, J. O; HELENIUS, H et al.Acta neuropathologica. 1999, Vol 98, Num 2, pp 157-164, issn 0001-6322Article

Semantic decision making in early probable AD: a PET activation studyRINNE, J. O; LAINE, M; HILTUNEN, J et al.Cognitive brain research. 2003, Vol 18, Num 1, pp 89-96, issn 0926-6410, 8 p.Article

An altered histaminergic innervation of the substantia nigra in Parkinson's diseaseANICHTCHIK, O. V; RINNE, J. O; KALIMO, H et al.Experimental neurology (Print). 2000, Vol 163, Num 1, pp 20-30, issn 0014-4886Conference Paper

Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageingMA, S. Y; RÖYTTÄ, M; COLLAN, Y et al.Neuropathology and applied neurobiology (Print). 1999, Vol 25, Num 5, pp 394-399, issn 0305-1846Article

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigraRINNE, J. O; RUMMUKAINEN, J; PALJARVI, L et al.Annals of neurology. 1989, Vol 26, Num 1, pp 47-50, issn 0364-5134Article

PET amyloid ligand [C]PIB uptake shows predominantly striatal increase in variant Alzheimer's diseaseKOIVUNEN, J; VERKKONIEMI, A; RINNE, J. O et al.Brain. 2008, Vol 131, pp 1845-1853, issn 0006-8950, 9 p., 7Article

Voxel-based analysis of PET amyloid ligand [¹¹C]PIB uptake in Alzheimer diseaseKEMPPAINEN, N. M; AALTO, S; PARKKOLA, R et al.Neurology. 2006, Vol 67, Num 9, pp 1575-1580, issn 0028-3878, 6 p.Article

Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's diseaseKEMPPAINEN, N; RÖYTTÄ, M; COLLAN, Y et al.Acta neuropathologica. 2002, Vol 103, Num 1, pp 43-47, issn 0001-6322Article

The A1 allele of the human D₂ dopamine receptor gene predicts low D₂ receptor availability in healthy volunteersPOHJALAINEN, T; RINNE, J. O; NAGREN, K et al.Molecular psychiatry. 1998, Vol 3, Num 3, pp 256-260, issn 1359-4184Article

Positron emission tomography study of human narcolepsy : no increase in striatal dopamine D₂ receptorsRINNE, J. O; HUBLIN, C; PARTINEN, M et al.Neurology. 1995, Vol 45, Num 9, pp 1735-1738, issn 0028-3878Article

Lyme borreliosis associated with complete flaccid paraplegiaSALONEN, R; RINNE, J. O; HALONEN, P et al.The Journal of infection. 1994, Vol 28, Num 2, pp 181-184, issn 0163-4453Article

Positron emission tomography demonstrates dopamine D₂ receptor supersensitivity in the striatum of patients with early Parkinson's diseaseRINNE, U. K; LAIHINEN, A; RINNE, J. O et al.Movement disorders. 1990, Vol 5, Num 1, pp 55-59, issn 0885-3185Article